Development and multi-observer validation of a histopathological scoring system for interstitial cystitis/bladder pain syndrome diagnosis
Open Access
- 17 July 2026
- journal article
- research article
- Published by Springer Nature in World Journal of Urology
- Vol. 44 (1) , 502
Abstract
Purpose To develop and validate a pragmatic histopathological scoring system for interstitial cystitis/bladder pain syndrome (IC/BPS) that distinguishes Hunner-type interstitial cystitis (HIC) from bladder pain syndrome (BPS) and inflammatory non-HIC chronic cystitis mimicking Hunner lesions (“other cystitis”). Methods Bladder biopsies from 96 patients were analyzed: HIC (n = 32), BPS (n = 42), and other cystitis (n = 22; bacillus Calmette–Guérin-related, follicular, and chronic bacterial cystitis). Four pathologists (A–D; A as index/model observer) independently scored hematoxylin-eosin sections using five histopathological features (inflammation, plasma cell infiltration, eosinophil infiltration, tertiary lymphoid structures, urothelial denudation; total 0–8). ROC curves were generated for HIC vs. BPS and HIC vs. other cystitis. Youden index–derived thresholds were compared across observers to select simple integer cutoffs and define an operational three-tier classification (0–2: BPS, 3–4: indeterminate, 5–8: HIC). Diagnostic performance was assessed using AUC and contingency-table metrics. Inter-observer agreement for the three-tier classification was evaluated using Fleiss’ kappa. Results HIC vs. BPS discrimination was excellent across pathologists (AUC 0.966–0.991; pooled AUC 0.983). HIC vs. other cystitis discrimination was moderate-to-good (AUC 0.723–0.808; pooled AUC 0.738). Overall agreement for the three-tier classification was 60.4% with Fleiss’ κ = 0.657; agreement was highest for BPS and modest for other cystitis. Conclusions This hematoxylin-eosin-based scoring system enables standardized IC/BPS phenotyping, robustly separating HIC from BPS and providing a structured framework for inflammatory overlap cases, with reproducible performance across international pathologists.Keywords
Funding Information
- Shinshu University
This publication has 15 references indexed in Scilit:
- Optimizing the Diagnosis of Interstitial Cystitis/Bladder Pain Syndrome: An ESSIC ProposalEuropean Urology Open Science, 2026
- Towards precision medicine in clinical trials for the treatment of urologic chronic pelvic pain syndrome: lessons from the MAPP Research NetworkNature Reviews Urology, 2025
- APRIL / BAFF upregulation is associated with clonal B‐cell expansion in Hunner‐type interstitial cystitisThe Journal of Pathology, 2024
- Genome-wide association study identifies risk loci within the major histocompatibility complex region for Hunner-type interstitial cystitisCell Reports Medicine, 2023
- European Association of Urology Guidelines on Non–muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)European Urology, 2022
- Hunner Lesion Phenotype in Interstitial Cystitis/Bladder Pain Syndrome: A Systematic Review and Meta-AnalysisJournal of Urology, 2020
- Hunner lesion disease differs in diagnosis, treatment and outcome from bladder pain syndrome: an ESSIC working group reportScandinavian Journal of Urology, 2020
- Estimation of the Youden Index and its Associated Cutoff PointBiometrical Journal, 2005
- Clinical Features and Spectrum of Light Microscopic Changes in Interstitial CystitisJournal of Urology, 1990
- Measuring nominal scale agreement among many raters.Psychological Bulletin, 1971